Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Mylan Inc    

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 10 885 M
EBIT 2016 3 277 M
Net income 2016 2 070 M
Debt 2016 10 187 M
Yield 2016 -
Sales 2017 13 130 M
EBIT 2017 4 231 M
Net income 2017 2 722 M
Debt 2017 10 074 M
Yield 2017 -
P/E ratio 2016 12,07
P/E ratio 2017 9,34
EV / Sales2016 2,97x
EV / Sales2017 2,45x
Capitalization 22 144 M
More Financials
Company
Mylan N.V., is a pharmaceutical company which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceutical products.It operates through two segments: Generic and Specialty.The Generic pharmaceutical business is conducted primarily in the U.S. and... 
Sector
Pharmaceuticals
Calendar
07/27Earnings Release
More about the company
Surperformance© ratings of Mylan Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on MYLAN INC
06/24 MYLAN NV : Launches Generic Avodart® Capsules
06/23 MYLAN NV : Donates EUR1 Million to the Princess Máxima Center for Pediatric Onco..
06/20 MYLAN NV : Attorney General Rejects VEB's Request Regarding Mylan Shareholder Ap..
06/16 MYLAN NV : to Commence Meda Offer on June 17
06/15 MYLAN NV : Completes Acquisition of Renaissance's Leading Topicals-Focused Speci..
06/03 MYLAN NV : Launches Generic Cleocin® Solution
06/02 MYLAN NV : Launches Generic Rythmol® Sustained-Release Capsules
06/02 MEDA : EU regulators to rule on Mylan's $7.2 billion Meda bid by July 6
06/01 MYLAN NV : Launches First Generic of Doxycycline Hyclate Delayed-Release Tablets..
06/01 MYLAN NV : Launches First Generic of Nuvigil® Tablets
More news
Sector news : Pharmaceuticals - NEC
02:32p TEVA PHARMACEUTICAL : and Antares Pharma Announce Launch of Generic Imitrex® in ..
02:01p VALEANT PHARMACEUTICALS INTL : Canadian Shopper Study Names Bausch + Lomb Most T..
01:20p VALEANT PHARMACEUTICALS INTL : Renaissance Technologies, Two Sigma, Leman Capita..
01:00p BRISTOL MYERS SQUIBB : Opdivo (nivolumab) Receives Breakthrough Therapy Designat..
12:17p EISAI : Scientific milestone reached in Eisai – UCL Alzheimer’s coll..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 Mylan (MYL) Heather M. Bresch on Q4 2014 Results - Earnings Call Transcript
2015 Mylan Q4 revenues up 15%, Specialty up 38%
2015 Mylan (MYL) Q4 2014 Results - Earnings Call Webcast
2015 Mylan EPS in-line, beats on revenue
2015 Notable earnings after Monday?s close
Advertisement
Chart MYLAN INC
Duration : Period :
Mylan Inc Technical Analysis Chart | US6285301072 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions